Product

Clonidine

Aliases
Catapres, Catapresan, Catapressan, Clondine (2 other aliases)

30 clinical trials

45 indications

Indication
Hot Flashes
Indication
Sciatica
Indication
Scoliosis
Indication
Delirium
Indication
frailty
Indication
Healthy
Indication
Insomnia
Indication
Withdrawal
Indication
Catatonia
Indication
Anxiety
Indication
Hypertension
Indication
Tachycardia
Indication
Breast Cancer
Indication
systolic
Indication
Aortic
Indication
Endometriosis
Indication
Pain
Indication
Acute
Indication
Surgery
Indication
Depression
Indication
Obesity
Indication
PTSD
Clinical trial
Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain
Status: Terminated, Estimated PCD: 2022-04-05
Clinical trial
Treatment of Orthostatic Intolerance
Status: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain
Status: Active (not recruiting), Estimated PCD: 2025-03-01
Clinical trial
Kratom Use Disorder Management Using Clonidine and/or Buprenorphine
Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Safe Ketamine-Based Therapy for Treatment Resistant Depression
Status: Completed, Estimated PCD: 2014-06-06
Clinical trial
A Placebo Controlled Study of Colesevelam in Fecal Incontinence
Status: Completed, Estimated PCD: 2022-04-14
Clinical trial
The PREVENT AGITATION Trial II - Children ≤1 Year
Status: Recruiting, Estimated PCD: 2026-01-31
Clinical trial
Repurposing Low-Dose Clonidine for PTSD in Veterans
Status: Recruiting, Estimated PCD: 2024-07-01